OraSure To Present Proposal For HIV Test Actual-Use Study At Blood Panel

A proposal for an actual-use study on the OraQuick Advance Rapid HIV oral fluid specimen test in support of OTC status will be presented by OraSure Technologies at an upcoming FDA advisory panel, according to FDA